CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.613

Change

-0.04 (-0.78)%

Market Cap

USD 0.61B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.15 (-0.35%)

USD 65.72B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-1.05 (-0.21%)

USD 10.57B
WRD:PA HSBC ETFs Public Limited Compa..

-0.11 (-0.35%)

USD 9.08B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-1.60 (-0.66%)

USD 7.63B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.80 (-0.19%)

USD 6.82B
HHH:PA HSBC ETFs Public Limited Compa..

-0.10 (-0.21%)

USD 6.67B
WLD:PA Lyxor UCITS MSCI World D-EUR

-1.07 (-0.33%)

USD 6.34B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.06 (-0.35%)

USD 5.17B
500U:PA Amundi Index Solutions - Amund..

-0.04 (-0.04%)

USD 4.71B
WSRI:PA Amundi MSCI World SRI Climate ..

-0.55 (-0.60%)

USD 3.99B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.99% 71% C- 72% C
Dividend Return N/A 7% C- 4% F
Total Return N/A 58% F 65% D
Trailing 12 Months  
Capital Gain -3.39% 11% F 37% F
Dividend Return N/A 51% F 48% F
Total Return N/A 5% F 16% F
Trailing 5 Years  
Capital Gain -19.68% 8% B- 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.68% 7% C- 23% F
Average Annual (5 Year Horizon)  
Capital Gain 1.62% 35% F 41% F
Dividend Return N/A 13% F 30% F
Total Return N/A 22% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 34% F 5% F
Risk Adjusted Return N/A 44% F 2% F
Market Capitalization 0.61B 75% C 74% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.